27 August 2026
Fifth Circuit backs FDA on tirzepatide pens
On Aug. 27, 2026, the Fifth Circuit affirmed FDA’s removal of Mounjaro and Zepbound injections from the shortage list.
The full briefing is in the app.
27 August 2026
On Aug. 27, 2026, the Fifth Circuit affirmed FDA’s removal of Mounjaro and Zepbound injections from the shortage list.
The full briefing is in the app.